microRNA mir-302 inhibits the tumorigenicity of human pluripotent stem cells

Do you know that microRNA mir-302 can inhibit the tumorigenicity of human pluripotent stem cells (PSC) by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways?

Study had shown that mir-302 suppresses both the cyclin E-CDK2 and cyclin D-CDK4/6 pathways to block the majority of G1-S cell cycle transition. Concurrent silencing of BMI-1 (a cancer stem cell marker) further promoted tumor suppressor function of p16Ink4a and p14/p19Arf directed against CDK4/6-mediated cell proliferation. In particular, mir-302 inhibits human pluripotent stem cell tumorigenicity by enhancing multiple G1 phase arrest pathways rather than by silencing p21Cip1.

For more information on this published paper, please click here (published on Cancer Research, November 15, 2010.)

Product Info
Mello Biotech offers the mirPS® mir-302 Electroporation Kit that efficiently delivers the complete mir-302 cluster into target cells. Studies had shown that mir-302 reprograms human somatic cells and cancer cells into iPS cells. The setup is easy and the process is oncogen free. To learn more about our product, visit us at
Mello Biotech or call us at 877-700-0RNA.